KR100609765B1 - 프로락틴 저하제 - Google Patents

프로락틴 저하제 Download PDF

Info

Publication number
KR100609765B1
KR100609765B1 KR1020017005832A KR20017005832A KR100609765B1 KR 100609765 B1 KR100609765 B1 KR 100609765B1 KR 1020017005832 A KR1020017005832 A KR 1020017005832A KR 20017005832 A KR20017005832 A KR 20017005832A KR 100609765 B1 KR100609765 B1 KR 100609765B1
Authority
KR
South Korea
Prior art keywords
ring
composition
formula
compound
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020017005832A
Other languages
English (en)
Korean (ko)
Other versions
KR20010080965A (ko
Inventor
부트케볼프강
자리휴베르투스
포프미카엘
크리스토펠볼케르
스펭글러바르바라
Original Assignee
비오노리카 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비오노리카 악티엔게젤샤프트 filed Critical 비오노리카 악티엔게젤샤프트
Publication of KR20010080965A publication Critical patent/KR20010080965A/ko
Application granted granted Critical
Publication of KR100609765B1 publication Critical patent/KR100609765B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05—Alcohols containing rings other than six-membered aromatic rings
    • C07C33/14—Alcohols containing rings other than six-membered aromatic rings containing six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/36—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.4.0) system, e.g. naphols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Fats And Perfumes (AREA)
KR1020017005832A 1998-11-19 1999-11-05 프로락틴 저하제 Expired - Fee Related KR100609765B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853476A DE19853476A1 (de) 1998-11-19 1998-11-19 Prolaktin-senkendes Mittel
DE19853476.0 1998-11-19

Publications (2)

Publication Number Publication Date
KR20010080965A KR20010080965A (ko) 2001-08-25
KR100609765B1 true KR100609765B1 (ko) 2006-08-09

Family

ID=7888392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017005832A Expired - Fee Related KR100609765B1 (ko) 1998-11-19 1999-11-05 프로락틴 저하제

Country Status (13)

Country Link
US (2) US6635672B1 (enExample)
EP (1) EP1131061B1 (enExample)
JP (1) JP4290889B2 (enExample)
KR (1) KR100609765B1 (enExample)
CN (1) CN1172664C (enExample)
AT (1) ATE296623T1 (enExample)
BR (1) BR9915514A (enExample)
DE (2) DE19853476A1 (enExample)
EA (1) EA004588B1 (enExample)
ES (1) ES2241373T3 (enExample)
PT (1) PT1131061E (enExample)
UA (1) UA75864C2 (enExample)
WO (1) WO2000030623A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076748A2 (en) * 2004-02-13 2005-08-25 Janakiram Chodavarapu Therapeutic composition and method for preparing from dodonaea sp
CN101948453B (zh) * 2006-05-23 2012-05-23 山东绿叶制药有限公司 Neo-克罗烷型二萜化合物及其应用
EP2556829B1 (en) 2011-08-10 2015-08-19 Universität Leipzig Bicyclic labdane diterpenes for use in the treatment of TRPC6 associated diseases
WO2013072332A1 (en) * 2011-11-14 2013-05-23 Givaudan Sa Methods of using antagonists of bitter taste receptors
CN103553919B (zh) * 2013-11-05 2014-12-31 成都中医药大学 一种萜类化合物及其制备方法和用途
CN103804330A (zh) * 2014-02-25 2014-05-21 中国药科大学 ent-半日花烷二萜衍生物的制备及抗肿瘤用途
CN105085449B (zh) * 2014-05-13 2019-03-26 上海中医药大学 半日花型二萜衍生物及其制备方法和应用
CN106565641B (zh) * 2016-11-14 2019-04-02 中国科学院昆明植物研究所 呋喃半日花烷二萜衍生物及其药物组合物和其在制药中的应用
EP3498306A1 (de) 2017-12-16 2019-06-19 Bionorica SE Extrakte aus vitex agnus castus zur behandlung und diagnose von brustkrebs
CN110305082A (zh) * 2019-08-21 2019-10-08 成都格利普生物科技有限公司 采用蔓荆子提取蔓荆呋喃的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883074A (en) 1995-02-08 1999-03-16 Microcide Pharmaceuticals, Inc. Potentiators of antibacterial agents
US6150381A (en) 1998-06-09 2000-11-21 R.J. Reynolds Tobacco Company Methods of treating microbial infection and therapeutic formulations therefor

Also Published As

Publication number Publication date
JP4290889B2 (ja) 2009-07-08
EA004588B1 (ru) 2004-06-24
DE19853476A1 (de) 2000-05-31
US6635672B1 (en) 2003-10-21
HK1037523A1 (en) 2002-02-15
JP2003521457A (ja) 2003-07-15
US20040138297A1 (en) 2004-07-15
ES2241373T3 (es) 2005-10-16
BR9915514A (pt) 2001-08-07
WO2000030623A2 (de) 2000-06-02
KR20010080965A (ko) 2001-08-25
DE59912125D1 (de) 2005-07-07
EP1131061B1 (de) 2005-06-01
PT1131061E (pt) 2005-08-31
CN1172664C (zh) 2004-10-27
ATE296623T1 (de) 2005-06-15
EP1131061A1 (de) 2001-09-12
EA200100564A1 (ru) 2001-10-22
UA75864C2 (en) 2006-06-15
WO2000030623A3 (de) 2000-08-31
CN1326343A (zh) 2001-12-12

Similar Documents

Publication Publication Date Title
JP5086111B2 (ja) 皮膚障害を治療し創傷の治癒を促進する植物抽出物の調製方法
Ammon et al. Pharmacology of Curcuma longa
CA2028581C (en) Compositions for treating fat deposits in humans
US20040138293A1 (en) Pharmaceutical composition made of cannabis extracts
KR100609765B1 (ko) 프로락틴 저하제
Bero et al. In vivo antimalarial activity of Keetia leucantha twigs extracts and in vitro antiplasmodial effect of their constituents
JP5478486B2 (ja) 植物抽出物及びその治療的使用
CZ19498A3 (cs) Použití glykosidů z měsíčku (Calendula) pro léčbu psoriasy
KR20130012979A (ko) 천심련으로부터의 조추출물
US4046914A (en) Therapeutically active substituted saturated and mono-and polyunsaturated alkyl-glycerylethers
RU2240304C2 (ru) Производные гиперфорина, их использование и препараты, содержащие эти производные
CN114539192B (zh) 松香烷型二萜化合物及其制备方法和应用
Mikail et al. New alkylresorcinols from a lipophilic extract of Urginea indica L. bulbs showing experimental trauma healing activity
HK1037523B (en) Agent for lowering prolactin
JPH0952899A (ja) ロイコトリエン拮抗剤
Asadi et al. Benzofurans nor-sesquiterpenoids from Petasites hybridus rhizomes and absolute configuration by circular dichroism
KR0143719B1 (ko) 백하수오로부터 추출한 암세포의 다중약제내성조절 작용을 갖는 폴리옥시프레그난 배당체
Ammar et al. Phytochemical and biological studies of butea frondosa Roxb. leaves growing in Egypt
Ayaz et al. Anti-inflammatory Activity of Sesquiterpene Lactones from Chrysophthalmum montanum (DC.) Boiss.
Siddiquea et al. New triglycerides from antimicrobial extracts of Nepeta hindostana weed
JPH08310993A (ja) ジテルペン類
CN120842183A (zh) 桥环型ppap类化合物及其药物组合物和其在制药中的应用
JP5620657B2 (ja) 日焼け細胞形成抑制剤
Nguyen et al. Hepatoprotective effect of isolated constituent from Polygonum tomentosum against carbon tetrachloride induced toxicity
Lwin ANTICANCER ACTIVITY OF VARIOUS KAN-ZAW EXTRACTS ON HUMAN CERVICAL CANCER CELLS (HELA)

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20120723

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

FPAY Annual fee payment

Payment date: 20130719

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20140729

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20150801

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20150801